Alzheimer’s Disease

Plasma p-tau181 to identify Alzheimer’s disease-related co-pathology in DLB

Recognizing and managing pain in the context of cognitive impairment

Gut microbiome composition and cognitive function in middle-aged adults

Time gap between amyloid- and tau-PET positivity in preclinical disease

Genetic risk scores and neuroimaging changes in the FINGER trial

Racial and ethnic minorities more likely to be excluded from trials based on biomarker prescreening

Ultra-high field 7T MRI for diagnosis of early Alzheimer’s Disease

24-hour activity rhythms associated with amyloid levels after 8 years

Impact of age, sex, and race on the association between APOE and Alzheimer’s disease

Phase I trial of NK cell therapy in advanced Alzheimer’s disease

Humanoid robots in improve quality of life in dementia care home residents

Later-life antidepressant use and dementia risk

Discriminative power of a multi-PET tracer approach in primary tauopathies

Behavioral changes and dementia risk

A single question dementia screening method

Retinal microglia and tau biomarkers in Alzheimer’s disease